Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 52% Improvement Relative Risk Ventilation 32% ICU admission 32% Vitamin D for COVID-19  Maghbooli et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 235 patients in Iran Lower mortality (p=0.075) and ventilation (p=0.49), not sig. c19early.org Maghbooli et al., PLOS One, September 2020 Favors vitamin D Favors control

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Maghbooli et al., PLOS One, doi:10.1371/journal.pone.0239799
Sep 2020  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Retrospective 235 hospitalized patients showing a significant association between vitamin D sufficiency and reduction in clinical severity.
For patients over 40, mortality was 9.7% with 25(OH)D levels >30ng/mL, versus 20% for <30ng/mL.
A significant reduction in serum CRP, an inflammatory marker, along with increased lymphocytes percentage suggest that vitamin D sufficiency may help modulate the immune response possibly by reducing the risk for cytokine storm in response to this viral infection.
This is the 15th of 196 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 11,637 vigintillion).
risk of death, 51.7% lower, RR 0.48, p = 0.08, high D levels 7 of 72 (9.7%), low D levels 27 of 134 (20.1%), NNT 9.6, age >40.
risk of mechanical ventilation, 31.6% lower, RR 0.68, p = 0.49, high D levels 6 of 77 (7.8%), low D levels 18 of 158 (11.4%), NNT 28.
risk of ICU admission, 32.0% lower, RR 0.68, p = 0.33, high D levels 11 of 77 (14.3%), low D levels 33 of 158 (20.9%), NNT 15, >30nmol/L.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Maghbooli et al., 25 Sep 2020, retrospective, Iran, peer-reviewed, 11 authors.
This PaperVitamin DAll
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Zhila Maghbooli, Mohammad Ali Sahraian, Mehdi Ebrahimi, Marzieh Pazoki, Samira Kafan, Hedieh Moradi Tabriz, Azar Hadadi, Mahnaz Montazeri, Mehrad Nasiri, Arash Shirvani, Michael F Holick
PLOS ONE, doi:10.1371/journal.pone.0239799
Background To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection. Study design The hospital data of 235 patients infected with COVID-19 were analyzed. Results Based on CDC criteria, among our study patients, 74% had severe COVID-19 infection and 32.8% were vitamin D sufficient. After adjusting for confounding factors, there was a significant association between vitamin D sufficiency and reduction in clinical severity, inpatient mortality serum levels of C-reactive protein (CRP) and an increase in lymphocyte percentage. Only 9.7% of patients older than 40 years who were vitamin D sufficient succumbed to the infection compared to 20% who had a circulating level of 25(OH)D< 30 ng/ml. The significant reduction in serum CRP, an inflammatory marker, along with increased lymphocytes percentage suggest that vitamin D sufficiency also may help modulate the immune response possibly by reducing risk for cytokine storm in response to this viral infection.
Supporting information S1 Video. (MP4) support. The authors are grateful to the members of the COVID-19 Crisis Committee of the Sina Hospital for their help and consult. Author Contributions Conceptualization: Zhila Maghbooli, Arash Shirvani, Michael F. Holick. Data curation: Zhila Maghbooli, Hedieh Moradi Tabriz, Mehrad Nasiri, Arash Shirvani. Formal analysis: Zhila Maghbooli, Arash Shirvani, Michael F. Holick. Investigation: Zhila Maghbooli, Mehdi Ebrahimi, Marzieh Pazoki, Samira Kafan, Azar Hadadi, Mahnaz Montazeri, Arash Shirvani. Methodology: Zhila Maghbooli, Mohammad Ali Sahraian, Michael F. Holick. Project administration: Zhila Maghbooli, Mohammad Ali Sahraian. Validation: Arash Shirvani. Writing -original draft: Zhila Maghbooli. Writing -review & editing: Mohammad Ali Sahraian, Mehdi Ebrahimi, Marzieh Pazoki, Samira Kafan, Hedieh Moradi Tabriz, Azar Hadadi, Mahnaz Montazeri, Mehrad Nasiri, Arash Shirvani, Michael F. Holick.
References
Beard, Bearden, Striker, Vitamin D and the anti-viral state, Pan American Society for Clinical Virology, doi:10.1016/j.jcv.2010.12.006
Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the Treatment of Covid-19-Preliminary Report, The New England journal of medicine, doi:10.1056/NEJMoa2007764
Berry, Hesketh, Power, Hypponen, Vitamin D status has a linear association with seasonal infections and lung function in British adults, The British journal of nutrition, doi:10.1017/S0007114511001991
Bikle, Extraskeletal actions of vitamin D, Annals of the New York Academy of Sciences, doi:10.1111/nyas.13219
Bordelon, Ghetu, Langan, Recognition and management of vitamin D deficiency. American family physician
Bruce, Ooi, Yu, Cantorna, Vitamin D and host resistance to infection? Putting the cart in front of the horse, Experimental biology and medicine, doi:10.1258/ebm.2010.010061
Chen, Wang, Chen, Novel Antiviral Strategies in the Treatment of COVID-19: A Review, Microorganisms, doi:10.3390/microorganisms8091259
Cucinotta, Vanelli, WHO Declares COVID-19 a Pandemic, Acta bio-medica: Atenei Parmensis, doi:10.23750/abm.v91i1.9397
Daneshkhah, Agrawal, Eshein, Subramanian, Roy et al., The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients
Dawson-Hughes, Mithal, Bonjour, Boonen, Burckhardt et al., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, doi:10.1007/s00198-010-1285-3
Gheblawi, Wang, Viveiros, Nguyen, Zhong et al., Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2, Circulation research, doi:10.1161/CIRCRESAHA.120.317015
Gruber-Bzura, Vitamin D and Influenza-Prevention or Therapy?, International journal of molecular sciences, doi:10.3390/ijms19082419
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, The Journal of Clinical Endocrinology & Metabolism
Hope-Simpson, The role of season in the epidemiology of influenza, The Journal of hygiene, doi:10.1017/s0022172400068728
Horby, Lim, Emberson, Mafham, Bell et al., Dexamethasone in Hospitalized Patients with Covid-19-Preliminary Report, The New England journal of medicine, doi:10.1056/NEJMoa2021436
Hossein-Nezhad, Holick, Editors, Vitamin D for health: a global perspective
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clinical and Experimental Research, doi:10.1007/s40520-020-01570-8
Joyner, Wright, Fairweather, Senefeld, Bruno et al., Early safety indicators of COVID-19 convalescent plasma in 5000 patients, The Journal of clinical investigation, doi:10.1172/jci140200
Kroll, Bi, Garber, Kaufman, Liu et al., Temporal relationship between vitamin D status and parathyroid hormone in the United States, PloS one, doi:10.1371/journal.pone.0118108
Lamers, Beumer, Van Der Vaart, Knoops, Puschhof et al., SARS-CoV-2 productively infects human gut enterocytes, Science, doi:10.1126/science.abc1669
Larijani, Hossein-Nezhad, Feizabad, Maghbooli, Adibi et al., Vitamin D deficiency, bone turnover markers and causative factors among adolescents: a cross-sectional study. Journal, of Diabetes & Metabolic Disorders, doi:10.1186/s40200-016-0266-2
Liu, Chen, Lin, Han, Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients, Journal of Infection, doi:10.1016/j.jinf.2020.03.005
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Niculescu, Deacu, Caragheorgheopol, Dusceac, Procopiuc et al., Seasonal periodicity of serum parathyroid hormone and its relation with vitamin D in Romania. Archives of Osteoporosis, doi:10.1007/s11657-020-00744-1
Ortega, Serrano, Pujol, Rangel, Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis, EXCLI journal, doi:10.17179/excli2020-1167
Ross, Manson, Abrams, Aloia, Brannon et al., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know, The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2010-2704
Shiozawa, Shiozawa, Shimizu, Fujita, 1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions, Immunology
Shirvani, Kalajian, Song, Holick, Disassociation of Vitamin D's calcemic Activity and non-calcemic Genomic Activity and individual Responsiveness: A Randomized controlled Double-Blind clinical trial, Scientific reports
Tabrizi, Moosazadeh, Akbari, Dabbaghmanesh, Mohamadkhani et al., High prevalence of vitamin d deficiency among iranian population: A systematic review and meta-analysis, Iranian journal of medical sciences
Talebpour, Hadadi, Oraii, Ashraf, Rationale and Design of a Registry in a Referral and Educational Medical Center in Tehran
Tan, Huang, Shi, Tan, Ma et al., C-reactive protein correlates with CT findings and predicts severe COVID-19 early, Journal of Medical Virology, doi:10.1002/jmv.25871
Tan, Wang, Zhang, Ding, Huang et al., Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy
Xu, Shi, Wang, Zhang, Huang et al., Pathological findings of COVID-19 associated with acute respiratory distress syndrome, The Lancet respiratory medicine, doi:10.1016/S2213-2600(20)30076-X
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharideinduced acute lung injury via regulation of the reninangiotensin system, Molecular medicine reports, doi:10.3892/mmr.2017.7546
Zhu, Zhang, Li, Yang, Song, A novel coronavirus from patients with pneumonia in China, New England Journal of Medicine, doi:10.1056/NEJMoa2001017
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit